by admin_prosemble | 5th September 2025 | News
We’re delighted to announce a significant expansion of the Prosemble team as we continue to grow our capabilities across both AI and life sciences. Please join us in welcoming our newest colleagues and consultants: Tamara Veres – AI/Bioinformatics Specialist (Dry Lab)...
by admin_prosemble | 4th September 2025 | News
Prosemble is pleased to announce that its Chief Financial Officer and Chief Operating Officer, Inna Zhuranskaya, attended the World Finance Forum – London Autumn 2025 this week. During the event, Ms Zhuranskaya met with Bili Eseanobi, Associate Director of Commercial...
by admin_prosemble | 3rd September 2025 | News
Inna Zhuranskaya recently attended the Twin Path Portfolio Day, an event bringing together leaders and innovators from across technology, healthcare, and venture capital. During the event, Inna met with James Rosenthal, Director, Global Strategic Initiatives, Google...
by admin_prosemble | 11th August 2025 | News
Prosemble is pleased to announce the commencement of the immunogenicity phase of its mouse trials, conducted in partnership with TransCure BioServices, following the successful completion of the safety stage. This new phase will assess immune responses in CD34+...
by admin_prosemble | 29th July 2025 | Scientific Publications
The structure of the Tad pilus alignment complex reveals a periplasmic conduit for pilus extension: https://www.nature.com/articles/s41467-025-62457-8
